← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 30, 2017Last known activity
May 23, 2025
Timeline
2010s
- Jun 1, 2013
TearSolutions, Inc.— Founded
Drugs by trial phase (1 distinct, 2 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (3)
- NCT06854393CollaboratorPhase 2May 23, 2025
- NCT03226444Study directorPhase 1/Phase 2Jun 30, 2017
- NCT03226444Lead sponsorPhase 1/Phase 2Jun 30, 2017
Details
- Founded
- Charlottesville, VA, US Jun 1, 2013
- Last known activity
- May 23, 2025